Vicarious Surgical Inc. (NYSE:RBOT) Short Interest Update

Vicarious Surgical Inc. (NYSE:RBOT) saw a significant increase in short interest in December. As of December 15th, there was short interest totaling 207,502 shares, an increase of 37.4% from the November 30th total of 151,012 shares. Based on an average daily trading volume, of 219,487 shares, the days-to-cover ratio is presently 0.9 days. Approximately 3.5% of the shares of the stock are short sold. Approximately 3.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 219,487 shares, the days-to-cover ratio is presently 0.9 days.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. BTIG Research reissued a “neutral” rating on shares of Vicarious Surgical in a report on Friday, December 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Vicarious Surgical to a “sell” rating in a research note on Saturday, September 13th. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Vicarious Surgical has an average rating of “Reduce” and an average price target of $7.00.

Vicarious Surgical Stock Performance

RBOT traded down $0.01 during trading on Tuesday, reaching $1.87. 105,507 shares of the company’s stock were exchanged, compared to its average volume of 54,766. The company’s fifty day moving average price is $3.47 and its 200-day moving average price is $6.05. The firm has a market capitalization of $12.25 million, a PE ratio of -0.21 and a beta of 1.51. Vicarious Surgical has a fifty-two week low of $1.81 and a fifty-two week high of $18.97.

Vicarious Surgical (NYSE:RBOT) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($1.91) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.37) by $0.46. Research analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Vicarious Surgical

Institutional investors have recently modified their holdings of the stock. DNB Asset Management AS increased its stake in shares of Vicarious Surgical by 12.1% in the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after acquiring an additional 3,154 shares during the last quarter. Connective Capital Management LLC acquired a new position in Vicarious Surgical during the third quarter valued at approximately $169,000. Finally, Dimensional Fund Advisors LP grew its holdings in Vicarious Surgical by 22.1% during the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after purchasing an additional 3,615 shares during the period. 47.27% of the stock is currently owned by institutional investors and hedge funds.

About Vicarious Surgical

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.